(Stroke. 1997;28:1418-1422.)
© 1997 American Heart Association, Inc.
Articles |
Diagnosis of Cerebral Amyloid Angiopathy
Sensitivity and Specificity of Cortical Biopsy
From the Department of Neurology (S.M.G.) and C.S. Kubik Laboratory for Neuropathology (J-P.G.V.), Massachusetts General Hospital, and Brain Tissue Resource Center, McLean Hospital (J-P.G.V.), Harvard Medical School, Boston, Mass.
Correspondence to Steven M. Greenberg, MD, PhD, WACC 836, Massachusetts General Hospital, Boston, MA 02114. E-mail greenberg{at}helix.mgh.harvard.edu
Background and Purpose Examination of cortical tissue obtained surgically is an important tool for diagnosis of cerebral amyloid angiopathy (CAA) during life. Analysis of a single sample of cortical tissue, however, might lead to conclusions that are either falsely positive (because of the high frequency of CAA in the healthy elderly) or falsely negative (because of the patchy distribution of CAA pathology). We therefore attempted to estimate the sensitivity and specificity of cortical biopsy for diagnosis of CAA as the cause of intracerebral hemorrhage.
Methods To simulate biopsy in CAA, we took biopsy-sized cortical samples from postmortem brains with known extents of CAA: either CAA-related hemorrhage or mild to severe CAA without hemorrhage. Samples were stained with the use of methods routinely available in surgical pathology laboratories and blindly examined for vascular amyloid and amyloid-related vasculopathic changes.
Results The presence of vascular amyloid was a sensitive marker for CAA-related hemorrhage, occurring in all 28 specimens from brains with hemorrhage. Conversely, the appearance of fibrinoid necrosis in amyloid-laden vessels was relatively specific for CAA-related hemorrhage. This finding occurred in 13 of the 28 specimens (46%) from brains with hemorrhage but in none of 27 sections from brains with mild CAA and in only 4 of 42 specimens with moderate to severe CAA without hemorrhage.
Conclusions These data help to define criteria for the diagnosis of CAA-related hemorrhage from surgical specimens.
Key Words: amyloid • biopsy • diagnosis • hemorrhage
This article has been cited by other articles:
 |
|
 |
|
  C. Salvarani, R. D. Brown Jr, K. T. Calamia, T. J. H. Christianson, J. Huston III, J. F. Meschia, C. Giannini, D. V. Miller, and G. G. Hunder Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy Rheumatology, November 1, 2008; 47(11): 1671 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kim, L. Onstead, S. Randle, R. Price, L. Smithson, C. Zwizinski, D. W. Dickson, T. Golde, and E. McGowan A{beta}40 Inhibits Amyloid Deposition In Vivo J. Neurosci., January 17, 2007; 27(3): 627 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kim, G.A. Ford, C.S. Kidwell, S. Starkman, F. Vinuela, G.R. Duckwiler, R. Jahan, J.L. Saver, and for the UCLA Intra-Arterial Thrombolysis Investiga Intra-Arterial Thrombolysis for Acute Stroke in Patients 80 and Older: A Comparison of Results in Patients Younger than 80 Years AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 159 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Thanvi and T. Robinson Sporadic cerebral amyloid angiopathy--an important cause of cerebral haemorrhage in older people Age Ageing, November 1, 2006; 35(6): 565 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Leblanc, J. F. Meschia, D. T. Stuss, and V. Hachinski Genetics of Vascular Cognitive Impairment: The Opportunity and the Challenges Stroke, January 1, 2006; 37(1): 248 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Ritter, D. W. Droste, K. Hegedus, R. Szepesi, D. G. Nabavi, L. Csiba, and E. B. Ringelstein Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients Neurology, April 12, 2005; 64(7): 1233 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Thal, K. Del Tredici, and H. Braak Neurodegeneration in Normal Brain Aging and Disease Sci. Aging Knowl. Environ., June 9, 2004; 2004(23): pe26 - pe26. [Abstract] [Full Text]
|
|
|
|
 |
|
 S Love Contribution of cerebral amyloid angiopathy to Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, January 1, 2004; 75(1): 1 - 4. [Full Text] [PDF]
|
|
|
|
|
|
G. K. Aguirre, J. M. Ellenbogen, J. Pollard, E. D. Stolzenberg, and S. L. Galetta Amyloid angiopathy Neurology, November 26, 2002; 59(10): 1656 - 1656. [Full Text] [PDF]
|
|
|
|
|
|
K. A. Knudsen, J. Rosand, D. Karluk, and S. M. Greenberg Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria Neurology, February 27, 2001; 56(4): 537 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rosand, E. M. Hylek, H. C. O'Donnell, and S. M. Greenberg Warfarin-associated hemorrhage and cerebral amyloid angiopathy: A genetic and pathologic study Neurology, October 10, 2000; 55(7): 947 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Caplan and D. N. Louis Case 10-2000- A 63-Year-Old Man with Changes in Behavior and Ataxia N. Engl. J. Med., March 30, 2000; 342(13): 957 - 965. [Full Text] [PDF]
|
|
|
|
|
|
D. Tanne, M. J. Gorman, V. E. Bates, S. E. Kasner, P. Scott, P. Verro, J. R. Binder, J. M. Dayno, L. R. Schultz, and S. R. Levine Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older : The tPA Stroke Survey Experience Stroke, February 1, 2000; 31(2): 370 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Morton-Bours, E. J. Skalabrin, and G. W. Albers Cerebral amyloid angiopathy with unilateral hemorrhages, mass effect, and meningeal enhancement Neurology, July 1, 1999; 53(1): 233 - 233. [Full Text]
|
|
|
|
|
|
R. Natte, H. V. Vinters, M. L. C. Maat-Schieman, M. Bornebroek, J. Haan, R. A. C. Roos, and S. G. van Duinen Microvasculopathy Is Associated With the Number of Cerebrovascular Lesions in Hereditary Cerebral Hemorrhage With Amyloidosis, Dutch Type Stroke, August 1, 1998; 29(8): 1588 - 1594. [Abstract] [Full Text] [PDF]
|
|